Current Filters

Showing 11 - 20 results of 2979

Ivabradine (Lancora) (Last Updated: Oct 11, 2016)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Lancora
Manufacturer:
Servier Canada Inc.
Submission Type:
Initial
Indications:

Heart failure, NYHA class II or III

Mifepristone and misoprostol (Mifegymiso) (Last Updated: Apr 20, 2017)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Mifegymiso
Manufacturer:
Celopharma Inc.
Submission Type:
Initial
Indications:

Medical termination of pregnancy

abobotulinumtoxinA (Dysport Therapeutic) (Last Updated: Jan 3, 2017)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Dysport Therapeutic
Manufacturer:
IPSEN Biopharmaceuticals Canada, Inc.
Submission Type:
Initial
Indications:

Cervical dystonia

Apremilast (Otezla) (Last Updated: Jan 29, 2016)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Otezla
Manufacturer:
Celgene
Submission Type:
Resubmission
Indications:

Psoriasis, moderate to severe plaque

Download results as CSV